Redox modifier genes in amyotrophic lateral sclerosis in mice

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset neurodegenerative disease with no cure.
• Redox stress and inflammation are implicated in ALS progression via unknown mechanisms.
• Mutant SOD1(G93A) expression is a common model for studying ALS pathogenesis.

Purpose of the Study:

• To investigate the role of NADPH oxidases (Nox1 and Nox2) in ALS progression.
• To determine if targeting Nox genes can modify disease course and survival in ALS models.
• To identify novel genetic targets for ALS treatment.

Main Methods:

• Utilized a mouse model of ALS expressing mutant SOD1(G93A).
• Generated knockout mice lacking Nox1 or Nox2 genes.
• Assessed disease progression rates, survival, and Nox activity in spinal cords.

Main Results:

• Deletion of Nox1 or Nox2 significantly slowed ALS disease progression and improved survival in mice.
• Nox2 deletion provided a greater survival benefit than Nox1 deletion.
• Reduced Nox activity in female mice with one active X-linked Nox gene delayed disease onset.

Conclusions:

• Dysregulated Nox1 and Nox2 activity exacerbates motor neuron degeneration in ALS.
• Targeting Nox genes represents a promising therapeutic strategy for ALS.
• Cellular chimerism affecting Nox expression can delay ALS onset, suggesting complex regulatory mechanisms.